Dr. Mohamad M. Al-Rahawan
Claim this profileUMC Cancer Center / UMC Health System
Studies Tumors
Studies Cancer
23 reported clinical trials
74 drugs studied
Area of expertise
1Tumors
Stage I
Stage II
Stage IV
2Cancer
Stage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Mohamad M. Al-Rahawan is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Mohamad M. Al-Rahawan
Clinical Trial Related7 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Mohamad M. Al-Rahawan has experience with
- Cyclophosphamide
- Etoposide
- Vincristine Sulfate
- Doxorubicin Hydrochloride
- Radiation Therapy
- Dexamethasone
Breakdown of trials Mohamad M. Al-Rahawan has run
Tumors
Cancer
Neuroblastoma
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohamad M. Al-Rahawan specialize in?
Mohamad M. Al-Rahawan focuses on Tumors and Cancer. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage II.
Is Mohamad M. Al-Rahawan currently recruiting for clinical trials?
Yes, Mohamad M. Al-Rahawan is currently recruiting for 6 clinical trials in Lubbock Texas. If you're interested in participating, you should apply.
Are there any treatments that Mohamad M. Al-Rahawan has studied deeply?
Yes, Mohamad M. Al-Rahawan has studied treatments such as Cyclophosphamide, Etoposide, Vincristine Sulfate.
What is the best way to schedule an appointment with Mohamad M. Al-Rahawan?
Apply for one of the trials that Mohamad M. Al-Rahawan is conducting.
What is the office address of Mohamad M. Al-Rahawan?
The office of Mohamad M. Al-Rahawan is located at: UMC Cancer Center / UMC Health System, Lubbock, Texas 79415 United States. This is the address for their practice at the UMC Cancer Center / UMC Health System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.